A Review of Commonly Prescribed Antiarrhythmics: Primer for Primary Care Providers, a Case Based Approach

Area of Science:

• Cardiology
• Pharmacology

Background:

• Increasing incidence of atrial fibrillation with aging populations.
• Prevalence of antiarrhythmic drug use for ventricular tachycardia in structural heart disease.
• Crucial role of general practitioners in co-managing cardiac patients.

Purpose of the Study:

• To provide primary care practitioners with a focused review of commonly used antiarrhythmic drugs.
• To aid in the safe prescription and follow-up of patients on antiarrhythmic therapy.
• To emphasize the importance of understanding drug mechanisms, side effects, and interactions.

Main Methods:

• Review of common antiarrhythmic drugs, specifically focusing on Class I and Class III agents.
• Discussion of basic pharmacology relevant to primary care.
• Emphasis on personalized medication selection based on patient co-morbidities.

Main Results:

• Highlights the need for practitioners to understand antiarrhythmic drug mechanisms.
• Underscores the significance of personalized treatment selection.
• Identifies Class I and Class III antiarrhythmic drugs as key areas for primary care focus.

Conclusions:

• Enhanced understanding of antiarrhythmic drug pharmacology is essential for safe patient management.
• Personalized antiarrhythmic therapy selection improves patient care.
• Primary care practitioners require practical guidance on utilizing Class I and III antiarrhythmic drugs effectively.